Hogan Lovells Publications
Life sciences and health care horizons 2021
23 February 2021
PartnerNorthern Virginia
Email cullen.taylor@hoganlovells.com
Phone +1 703 610 6177
Fax +1 703 610 6200
LanguagesEnglish, Spanish
Practice groupIntellectual Property, Media, and Technology
Cullen Taylor helps companies structure and negotiate their most complex commercial transactions, particularly those involving the development, acquisition, and commercialization of intellectual property and technology. Cullen takes a practical, results-oriented approach to getting deals done, drawing on his broad experience across multiple industries to anticipate and address problems before they arise.
Trained as an intellectual property lawyer, Cullen understands the technical and business issues that arise as parties enter, live under, and exit long-term commercial arrangements. Cullen is skilled at structuring and drafting contracts that address these concerns while keeping the client's business goals at front and center.
Given his versatility, Cullen practices across a variety of industries, including life sciences, communications, sports, information technology, and media. In the life sciences industries, Cullen handles a variety of transactions, including product acquisition, licensing, development, collaboration, manufacture, supply, and co-promotion agreements. In the cable and communications fields, Cullen advises clients in connection with network, transport, interconnection, cell tower backhaul, hosting, co-location, and other communications service agreements.
Cullen is Co-Head (Americas) of the firm's Life Sciences Transactions team. He regularly collaborates with his colleagues in the firm's Corporate practice to address intellectual property and technology-related issues that arise in mergers, acquisitions, and other corporate transactions.
BTI Client Service All-Star
BTI Consulting Group
Rising Star
Virginia Super Lawyers
Rising Star
Washington, D.C. Super Lawyers
Intellectual Property
Virginia Legal Elite
Young Lawyer
Virginia Legal Elite
Health Law
Virginia Legal Elite
Media, Technology, and Telecoms: Technology Transactions
Legal 500 US
Education
J.D., Harvard Law School, 2000
B.A., University of Virginia, with distinction, Phi Beta Kappa, 1997
Memberships
Member, American Bar Association
Member, Intellectual Property Owners Association
Member, Raven Society
Member, Virginia Bar Association
Bar admissions and qualifications
Virginia
Representing Gilead Sciences in its collaboration with Yuhan Corporation to co-develop novel therapeutics for patients with advanced fibrosis due to NASH.
Representing Incyte Corporation in its license and collaboration agreement with MacroGenics relating to an anti-PD-1 antibody.
Representing multiple pharmaceutical companies and diagnostics manufacturers in collaboration agreements to develop companion diagnostics for drug products.
Representing Regeneron in a genomics collaboration with Geisinger Health Systems.
Representing Helsinn Healthcare in connection with license and collaboration agreements with MEI Pharma and Taiho Pharmaceuticals.
Representing Helsinn Therapeutics in its co-promotion agreement with Novartis relating to Zykadia.
Representing Cormedix in various license, collaboration, supply, and distribution agreements relating to its Neutrolin product.
Representing Daiichi Sankyo in its co-commercialization agreement with AstraZeneca relating to MOVANTIK in the United States.
Representing Naver on the acquisition of Xerox Research Centre Europe.
Representing Novartis in the sale of its animal health business to Eli Lilly for approximately US$5.4bn.
Ongoing representation of Charter Communications in connection with a variety of commercial agreements.
Ongoing representation of the College Football Playoff in connection with various commercial agreements.
Hogan Lovells Publications
23 February 2021
Press Releases
20 August 2020
Press Releases
24 April 2020
Press Releases
02 April 2020
News
15 March 2019
Sponsorships and Speaking Engagements
17 October 2018